The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Impact of Estrogen Receptor β on Gene Networks Regulated by Estrogen Receptor α in Breast Cancer Cells
Abstract
Two subtypes of the estrogen receptor (ER), ERα and ERβ, mediate the actions of estrogens, and although 70% of human breast cancers express ERβ along with ERα, little is known about the possible comodulatory effects of these two ERs. To investigate this, we have used adenoviral gene delivery to produce human breast cancer (MCF-7) cells expressing different levels of ERβ, along with their endogenous ERα, and have examined the effects of ERβ and receptor occupancy, using ER subtype selective ligands, on genome-wide gene expression by microarray and pathway network analysis. ERβ had diverse effects on gene expression, enhancing or counteracting ERα regulation for distinct subsets of estrogen target genes. Strikingly, ERβ in the absence of estradiol (E2), elicited the stimulation or suppression of many genes that were normally only regulated by ERα with E2. In addition, ERβ plus E2 elicited the expression of a unique group of genes that were not regulated by ERα plus E2 alone. The expression of genes in many functional categories were modulated by ERβ, with the greatest numbers associated with transcription factors and signal transduction pathways. Regulation of multiple components in the TGFβ and semaphorin pathways, and of genes controlling cell cycle progression and apoptosis, may contribute to the suppression of cell proliferation observed with ERβ. Our observations suggest that the relative levels of ERβ and ERα in breast cancers are likely to impact cell proliferation and the activities of diverse signaling pathways and their response to ER ligands and endocrine therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077
KEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
In silico prediction of protein-protein interactions in human macrophages
Souiai, O., Guerfali, F., Ben Miled, S., Brun, C., & Benkahla, A. (2014) · BMC Research Notes · doi:10.1186/1756-0500-7-157 · Cited by 10,803
Significance analysis of microarrays applied to the ionizing radiation response
Tusher, V. G., Tibshirani, R., & Chu, G. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.091062498 · Cited by 10,568
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Cloning of a novel receptor expressed in rat prostate and ovary.
Kuiper, G. G., Enmark, E., Pelto-Huikko, M., Nilsson, S., & Gustafsson, J. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.12.5925 · Cited by 4,788
Genes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
A multigenic program mediating breast cancer metastasis to bone
Kang, Y., Siegel, P. M., Shu, W., Drobnjak, M., Kakonen, S. M., Cordón-Cardo, C., Guise, T. A., & Massagué, J. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00132-6 · Cited by 2,597
ERβ: Identification and characterization of a novel human estrogen receptor
Mosselman, S., Polman, J., & Dijkema, R. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00782-x · Cited by 2,269
Munger, J. S., Huang, X., Kawakatsu, H., Griffiths, M. J. D., Dalton, S. L., Wu, J., Pittet, J.-F., Kaminski, N., Garat, C., Matthay, M. A., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80545-0 · Cited by 2,076
Nilsson, S., Mäkelä, S., Treuter, E., Tujague, M., Thomsen, J., Andersson, G., Enmark, E., Pettersson, K., Warner, M., & Gustafsson, J.-Å. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.4.1535 · Cited by 1,996
Identifying biological themes within lists of genes with EASE
Hosack, D. A., Dennis, G., Sherman, B. T., Lane, H. C., & Lempicki, R. A. (2003) · Genome Biology · doi:10.1186/gb-2003-4-10-r70 · Cited by 1,950
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
Paech, K., Webb, P., Kuiper, G. G. J. M., Nilsson, S., Gustafsson, J.-Å., Kushner, P. J., & Scanlan, T. S. (1997) · Science · doi:10.1126/science.277.5331.1508 · Cited by 1,861
A Model-Based Background Adjustment for Oligonucleotide Expression Arrays
Wu, Z., Irizarry, R. A., Gentleman, R., Martinez-Murillo, F., & Spencer, F. (2004) · Journal of the American Statistical Association · doi:10.1198/016214504000000683 · Cited by 1,716
Zeisberg, M., Hanai, J.-I., Sugimoto, H., Mammoto, T., Charytan, D., Strutz, F., & Kalluri, R. (2003) · Nature Medicine · doi:10.1038/nm888 · Cited by 1,346
Berthois, Y., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.8.2496 · Cited by 1,307
Self-citationNeuropilin Is a Semaphorin III Receptor
Kolodkin, A. L., Levengood, D. V., Rowe, E. G., Tai, Y.-T., Giger, R. J., & Ginty, D. D. (1997) · Cell · doi:10.1016/s0092-8674(00)80535-8 · Cited by 1,180
Tamagnone, L., Artigiani, S., Chen, H., He, Z., Ming, G.-L., Song, H.-J., Chedotal, A., Winberg, M. L., Goodman, C. S., Poo, M.-M., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80063-x · Cited by 1,157
Hall, J. M., & McDonnell, D. P. (1999) · Endocrinology · doi:10.1210/endo.140.12.7179 · Cited by 1,075
GenMAPP, a new tool for viewing and analyzing microarray data on biological pathways
Dahlquist, K. D., Salomonis, N., Vranizan, K., Lawlor, S. C., & Conklin, B. R. (2002) · Nature Genetics · doi:10.1038/ng0502-19 · Cited by 958
Endocrine-responsive breast cancer and strategies for combating resistance
Ali, S., & Coombes, R. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc721 · Cited by 883
Frasor, J., Danes, J. M., Komm, B., Chang, K. C. N., Lyttle, C. R., & Katzenellenbogen, B. S. (2003) · Endocrinology · doi:10.1210/en.2003-0567 · Cited by 876
Self-citationFoxM1 is required for execution of the mitotic programme and chromosome stability
Laoukili, J., Kooistra, M. R. H., Brás, A., Kauw, J., Kerkhoven, R. M., Morrison, A., Clevers, H., & Medema, R. H. (2005) · Nature Cell Biology · doi:10.1038/ncb1217 · Cited by 807
Stauffer, S. R., Coletta, C. J., Tedesco, R., Nishiguchi, G., Carlson, K., Sun, J., Katzenellenbogen, B. S., & Katzenellenbogen, J. A. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000170m · Cited by 760
Self-citationClass 3 semaphorins control vascular morphogenesis by inhibiting integrin function
Serini, G., Valdembri, D., Zanivan, S., Morterra, G., Burkhardt, C., Caccavari, F., Zammataro, L., Primo, L., Tamagnone, L., Logan, M., et al. (2003) · Nature · doi:10.1038/nature01784 · Cited by 576
Paruthiyil, S., Parmar, H., Kerekatte, V., Cunha, G. R., Firestone, G. L., & Leitman, D. C. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2446 · Cited by 576
Ström, A., Hartman, J., Foster, J. S., Kietz, S., Wimalasena, J., & Gustafsson, J.-Å. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308319100 · Cited by 534
Negative Feedback Regulation of TGF-β Signaling by the SnoN Oncoprotein
Stroschein, S. L., Wang, W., Zhou, S., Zhou, Q., & Luo, K. (1999) · Science · doi:10.1126/science.286.5440.771 · Cited by 492
Lindberg, M. K., Movérare, S., Skrtic, S., Gao, H., Dahlman-Wright, K., Gustafsson, J.-A., & Ohlsson, C. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0206 · Cited by 479
Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.
Roger, P., Sahla, M. E., Mäkelä, S., Gustafsson, J. A., Baldet, P., & Rochefort, H. (2001) · PubMed · Cited by 471
Tremblay, A., Tremblay, G. B., Labrie, F., & Giguère, V. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80479-7 · Cited by 464
Opposing Action of Estrogen Receptors α and β on Cyclin D1 Gene Expression
Liu, M.-M., Albanese, C., Anderson, C. M., Hilty, K., Webb, P., Uht, R. M., Price, R. H., Pestell, R. G., & Kushner, P. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201829200 · Cited by 422
Growth Factors in Breast Cancer
DICKSON, R. B., & LIPPMAN, M. E. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-5-559 · Cited by 388
Terman, J. R., Mao, T., Pasterkamp, R. J., Yu, H.-H., & Kolodkin, A. L. (2002) · Cell · doi:10.1016/s0092-8674(02)00794-8 · Cited by 367
Estrogen-Regulated Genes Predict Survival in Hormone Receptor–Positive Breast Cancers
Oh, D. S., Troester, M. A., Usary, J., Hu, Z., He, X., Fan, C., Wu, J., Carey, L. A., & Perou, C. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.2755 · Cited by 356
Wang, X., Kiyokawa, H., Dennewitz, M. B., & Costa, R. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.252570299 · Cited by 327
Sun, J., Meyers, M. J., Fink, B. E., Rajendran, R., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (1999) · Endocrinology · doi:10.1210/endo.140.2.6480 · Cited by 315
Self-citationHarrington, W. R., Sheng, S., Barnett, D. H., Petz, L. N., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2003) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(03)00255-7 · Cited by 300
Self-citationHall, J. M., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0438 · Cited by 293
McInerney, E. M., Weis, K. E., Sun, J., Mosselman, S., & Katzenellenbogen, B. S. (1998) · Endocrinology · doi:10.1210/endo.139.11.6298 · Cited by 269
Self-citationHall, J. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.3.469 · Cited by 253
Chalasani, S. H., Sabelko, K. A., Sunshine, M. J., Littman, D. R., & Raper, J. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01360.2003 · Cited by 232
Kurebayashi, J., Otsuki, T., Kunisue, H., Tanaka, K., Yamamoto, S., & Sonoo, H. (2000) · PubMed · Cited by 226
Stossi, F., Barnett, D. H., Frasor, J., Komm, B., Lyttle, C. R., & Katzenellenbogen, B. S. (2004) · Endocrinology · doi:10.1210/en.2003-1682 · Cited by 219
Self-citationThe brain within the tumor: new roles for axon guidance molecules in cancers
Chédotal, A., Kerjan, G., & Moreau-Fauvarque, C. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401707 · Cited by 219
Kraichely, D. M., Sun, J., Katzenellenbogen, J. A., & Katzenellenbogen, B. S. (2000) · Endocrinology · doi:10.1210/endo.141.10.7698 · Cited by 217
Self-citationEstrogen receptors: selective ligands, partners, and distinctive pharmacology.
Katzenellenbogen, B. S., Montano, M. M., Ediger, T. R., Sun, J., Ekena, K., Lazennec, G., Martini, P. G. V., McInerney, E. M., Delage-Mourroux, R., Weis, K. E., et al. (2000) · PubMed · Cited by 202
Self-citationCastro-Rivera, E., Ran, S., Thorpe, P., & Minna, J. D. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403969101 · Cited by 188
Páez-Pereda, M., Giacomini, D., Refojo, D., Nagashima, A. C., Hopfner, U., Grübler, Y., Chervin, A., Goldberg, V., Goya, R., Hentges, S. T., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237312100 · Cited by 174
Therapeutic targeting in the estrogen receptor hormonal pathway
Katzenellenbogen, B. S., & Frasor, J. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.01.004 · Cited by 159
Self-citationMonroe, D. G., Getz, B. J., Johnsen, S. A., Riggs, B. L., Khosla, S., & Spelsberg, T. C. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10633 · Cited by 158
TGIF2 Interacts with Histone Deacetylase 1 and Represses Transcription
Melhuish, T. A., Gallo, C. M., & Wotton, D. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103377200 · Cited by 137
Oestrogen receptor β: what it means for patients with breast cancer
Speirs, V., Carder, P. J., Lane, S., Dodwell, D. J., Lansdown, M., & Hanby, A. M. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01413-5 · Cited by 134
Brünner, N., Frandsen, T. L., Holst‐Hansen, C., Bei, M., Thompson, E. W., Wakeling, A. E., Lippman, M. E., & Clarke, R. C. (1993) · PubMed · Cited by 103
Cross-Talk between Bone Morphogenic Proteins and Estrogen Receptor Signaling
Yamamoto, T., Saatcioglu, F., & Matsuda, T. (2002) · Endocrinology · doi:10.1210/endo.143.7.8877 · Cited by 96
Johnsen, S. A., Subramaniam, M., Katagiri, T., Janknecht, R., & Spelsberg, T. C. (2002) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10299 · Cited by 77
Bilirubin Can Induce Tolerance to Islet Allografts
Wang, H., Lee, S. S., Dell’Agnello, C., Tchipashvili, V., D’Avilla, J., Czismadia, E., Chin, B. Y., & Bach, F. H. (2005) · Endocrinology · doi:10.1210/en.2005-0632 · Cited by 72
Lazennec, G., Alcorn, J. L., & Katzenellenbogen, B. S. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0318 · Cited by 67
Self-citationColeman, K. M., Dutertre, M., El-Gharbawy, A., Rowan, B. G., Weigel, N. L., & Smith, C. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212312200 · Cited by 63
Identification of Semaphorin3B as a Direct Target of p53
Ochi, K., Mori, T., Toyama, Y., Nakamura, Y., & Arakawa, H. (2002) · Neoplasia · doi:10.1038/sj.neo.7900211 · Cited by 62
Herman, M. E., & Katzenellenbogen, B. S. (1996) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00114-8 · Cited by 61
Self-citationYee, K. O., Streit, M., Hawighorst, T., Detmar, M. J., & Lawler, J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63319-6 · Cited by 60
Choi, I., Ko, C. J., Park-Sarge, O.-K., Nie, R., Hess, R. A., Graves, C. N., & Katzenellenbogen, B. S. (2001) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(01)00492-0 · Cited by 59
Self-citationCho, H., Ng, P. A. B., & Katzenellenbogen, B. S. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-9-1323 · Cited by 56
Self-citationHeldring, N., Nilsson, M., Buehrer, B., Treuter, E., & Gustafsson, J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.8.3445-3459.2004 · Cited by 50
Cited by
The pros and cons of phytoestrogens
Patisaul, H. B., & Jefferson, W. (2010) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2010.03.003 · Cited by 746
Estrogen receptors alpha (ERα) and beta (ERβ): Subtype-selective ligands and clinical potential
Paterni, I., Granchi, C., Katzenellenbogen, J. A., & Minutolo, F. (2014) · Steroids · doi:10.1016/j.steroids.2014.06.012 · Cited by 721
Estrogen receptor alpha and beta in health and disease
Jia, M., Dahlman-Wright, K., & Gustafsson, J.-Å. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.04.008 · Cited by 540
Molecular mechanism of estrogen–estrogen receptor signaling
Yaşar, P., Ayaz, G., User, S. D., Güpür, G., & Muyan, M. (2017) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12006 · Cited by 482
Estrogen Receptor β: An Overview and Update
Zhao, C., Dahlman-Wright, K., & Gustafsson, J.-Å. (2008) · Nuclear Receptor Signaling · doi:10.1621/nrs.06003 · Cited by 309
Metadata
- Authors
- Chang, E. C., Frasor, J., Komm, B., & Katzenellenbogen, B. S.
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2006-10-01
- Volume
- 147
- Issue
- 10
- Pages
- 4831-4842
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2123674503
- Cited by
- 325
- References
- 66
- FWCI
- 12.55
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.